CLINICAL_TRIALS
trial_result
· 2016-12-22
Clinical Trial Update: Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes [Phase 3]
Summary
Phase 3 trial comparing insulin aspart with regular human insulin in gestational diabetes has completed, evaluating safety and efficacy.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Gestational Diabetes | Phase 3 | Status: COMPLETED